Results 91 to 100 of about 111,424 (313)
Vermont prescription drug legislation
Title from Web page (viewed July 15, 2008).; "June 28, 2002."; Discusses recently enacted Vermont legislation on prescription drug cost control and access.; Harvested from the web on 7/15 ...
Kasprak, John.
core
Aim We aimed to investigate whether genetic variation is associated with venous thromboembolism after immunization with SARS‐CoV‐2 vaccines. Methods We conducted a genome‐wide association study (GWAS) on cases of venous thromboembolism within 42 days after SARS‐CoV‐2 vaccination, recruited from reports of adverse drug reactions sent to the Swedish ...
Sofia Attelind +7 more
wiley +1 more source
Aims The Black Triangle Scheme, introduced in 2018 in Australia, does not appear to have increased the quantity of adverse drug event (ADE) reports. This study evaluated healthcare professionals' (HCPs') and consumers' awareness of the scheme, its influence on intentions for future ADE reporting, and suggested improvements.
Eyob Alemayehu Gebreyohannes +7 more
wiley +1 more source
Melissa officinalis L. (lemon balm) is a Lamiaceae species widely used in traditional and contemporary herbal practice, yet its reported bioactivities are strongly preparation-dependent, reflecting variability between polyphenol-rich extracts and ...
Ioan-Alexandru Cîmpeanu +7 more
doaj +1 more source
Government introduces emergency legislation following Court of Appeal judgment.
The Government is introducing emergency legislation following a decision today by the Court of Appeal regarding a challenge to the Misuse of Drugs Act 1977.
core
Aim The purpose of this study is to evaluate safety, tolerability, pharmacokinetics (PK), food‐effect (FE) and pharmacodynamics (PD) of an oral tyrosine kinase‐2 (TYK2)/Janus kinase‐1 (JAK1) inhibitor, SDC‐1801, in healthy adult participants. Methods This first‐in‐human study randomized 95 male and female participants.
Chris Brearley +3 more
wiley +1 more source
In this Policy Forum piece, Robin Feldman discusses how current legislation contributes to informational deficits around drug patents for biologic drugs in the United States.
Robin Feldman
doaj +1 more source
Despite the increasingly strict legislation on medicinal products, the „off-label use“ or „use of medicinal product outside the approved summary of product characteristics (SmPC)“ is a weak point of today’s drug regulation and raises many questions about
Drenska M., Getov I.
doaj +1 more source
Legislation to address street trading of benzodiazepines ‘due in early 2013′.
LEGISLATION THAT WILL address the street-trading of Benzodiazepines is expected to be brought in in 2013. Deputy Róisín Shortall said last May that new legislation is being drafted that will make it illegal to possess benzodiazepines without ...
core
Abstract Aims Risk minimization measures (RMMs) are key regulatory tools to ensure safe medicinal product use. Regulatory guidelines recommend pre‐specifying the targets, or ‘thresholds’, for assessing RMM effectiveness. We aimed to review recent industry‐sponsored post‐authorization safety studies (PASS) that evaluated the effectiveness of RMMs ...
Kexin Zhu +7 more
wiley +1 more source

